f In 2004, a previously undiscovered mycobacterium resembling Mycobacterium ulcerans (the agent of Buruli ulcer) was reported in an outbreak of a lethal mycobacteriosis in a laboratory colony of the African clawed frog Xenopus tropicalis. This mycobacterium makes mycolactone and is one of several strains of M. ulcerans-like mycolactone-producing mycobacteria recovered from ectotherms around the world. Here, we describe the complete 6,399,543-bp genome of this frog pathogen (previously unofficially named "Mycobacterium liflandii"), and we show that it has undergone an intermediate degree of reductive evolution between the M. ulcerans Agy99 strain and the fish pathogen Mycobacterium marinum M strain. Like M. ulcerans Agy99, it has the pMUM mycolactone plasmid, over 200 chromosomal copies of the insertion sequence IS2404, and a high proportion of pseudogenes. However, M. liflandii has a larger genome that is closer in length, sequence, and architecture to M. marinum M than to M. ulcerans Agy99, suggesting that the M. ulcerans Agy99 strain has undergone accelerated evolution. Scrutiny of the genes specifically lost suggests that M. liflandii is a tryptophan, tyrosine, and phenylalanine auxotroph. A once-extensive M. marinum-like secondary metabolome has also been diminished through reductive evolution. Our analysis shows that M. liflandii, like M. ulcerans Agy99, has the characteristics of a niche-adapted mycobacterium but also has several distinctive features in important metabolic pathways that suggest that it is responding to different environmental pressures, supporting earlier proposals that it could be considered an M. ulcerans ecotype, hence the name M. ulcerans ecovar Liflandii.A n interesting member of the Mycobacterium marinum and Mycobacterium ulcerans complex was discovered in the summer of 2001, when an outbreak of generalized cutaneous lesions developed in a colony of Xenopus tropicalis at the University of Berkeley in California (1). Infected frogs developed granulomatous skin lesions along with coelomic distention, generalized edema, and septicemia (1). Cytological examinations confirmed the presence of acid-fast bacilli in smears from the liver, spleen, kidney, and skin. Based on histopathology and some molecular testing, it was concluded that these frogs were suffering from a mycobacteriosis caused by a Mycobacterium ulcerans-like bacterium (1). There have been ongoing reports and high lethality of this disease in captive frogs across the United States and those imported from the United States to Europe (2-4), but this mycobacterium has not been reported to cause illness in humans. Further characterization of the frog pathogen revealed that it harbored the M. ulcerans pMUM megaplasmid and produced mycolactone E, a unique structural variant of the polyketide toxin that is key for pathogenesis in M. ulcerans (5, 6). Limited genotype analysis suggests that a single clone of this pathogen is circulating worldwide in institutions housing and breeding anurans. The species name "Mycobacterium liflandii" w...